{{Rsnum
|rsid=1053096
|Chromosome=2
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=NPAS2
|position=100996153
|Gene_s=NPAS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.8 | 40.7 | 11.5
| HCB | 24.8 | 40.9 | 34.3
| JPT | 22.1 | 51.3 | 26.5
| YRI | 26.7 | 54.1 | 19.2
| ASW | 19.3 | 54.4 | 26.3
| CHB | 24.8 | 40.9 | 34.3
| CHD | 10.1 | 48.6 | 41.3
| GIH | 30.0 | 45.0 | 25.0
| LWK | 11.8 | 43.6 | 44.5
| MEX | 50.0 | 37.9 | 12.1
| MKK | 28.8 | 48.4 | 22.9
| TSI | 58.8 | 31.4 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=24754267
|Title=Functional polymorphisms in NPAS2 gene are associated with overall survival in TACE-treated hepatocellular carcinoma patients
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}